|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print January 12, 2006
Biology, MIT, Whitehead Institute, Cambridge, MA 02142
Corresponding Author: lodish{at}wi.mit.edu
In the absence of erythropoietin (Epo) cell surface Epo receptors (EpoR) are dimeric; dimerization is mediated mainly by the transmembrane domain. Binding of Epo changes the orientation of the two receptor subunits. This conformational change is transmitted through the juxtamembrane and transmembrane domains, leading to activation of JAK kinases and induction of proliferation and survival signals. To define the active EpoR conformation(s) we screened libraries of EpoRs with random mutations in the transmembrane domain and identified several point mutations that activate the EpoR in the absence of ligand, including changes of either of the first two transmembrane domain residues (L226 and I227) to cysteine. Following this discovery, we performed cysteine-scanning mutagenesis in the EpoR juxtamembrane and transmembrane domains. Many mutants formed disulfide-linked receptor dimers, but only EpoR dimers linked by cysteines at positions 223, 226 or 227 activated EpoR signal transduction pathways and supported proliferation of Ba/F3 cells in the absence of cytokines. These data suggest that activation of dimeric EpoR by Epo binding is achieved by reorienting the EpoR transmembrane and the connected cytosolic domains and that certain disulfide-bonded dimers represent the activated dimeric conformation of the EpoR, constitutively activating downstream signaling. Based on our data and the previously determined structure of Epo bound to a dimer of the EpoR extracellular domain, we present a model of the active and inactive conformations of the Epo receptor.
J. Biol. Chem, 10.1074/jbc.M512638200
Submitted on November 28, 2005
Revised on January 11, 2006
Accepted on January 12, 2006
Active conformation of the erythropoietin receptor: Random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Palani and C. A. Sarkar Positive Receptor Feedback during Lineage Commitment Can Generate Ultrasensitivity to Ligand and Confer Robustness to a Bistable Switch Biophys. J., August 15, 2008; 95(4): 1575 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Liu, S. I. Zakharov, L. Yang, S.-X. Deng, D. W. Landry, A. Karlin, and S. O. Marx Position and Role of the BK Channel {alpha} Subunit S0 Helix Inferred from Disulfide Crosslinking J. Gen. Physiol., June 1, 2008; 131(6): 537 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-J. Kim, S. H. Park, S. J. Opella, T. H. Marsilje, P.-Y. Michellys, H. M. Seidel, and S.-S. Tian NMR Structural Studies of Interactions of a Small, Nonpeptidyl Tpo Mimic with the Thrombopoietin Receptor Extracellular Juxtamembrane and Transmembrane Domains J. Biol. Chem., May 11, 2007; 282(19): 14253 - 14261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kawahara, H. Ueda, K. Tsumoto, I. Kumagai, and T. Nagamune Mimicry of Erythropoietin and Interleukin-6 Signalling by an Antibody/Cytokine Receptor Chimera in Murine Myeloid 32D Cells J. Biochem., April 1, 2007; 141(4): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Campbell and A. R. Green The Myeloproliferative Disorders N. Engl. J. Med., December 7, 2006; 355(23): 2452 - 2466. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pelletier, S. Gingras, M. Funakoshi-Tago, S. Howell, and J. N. Ihle Two Domains of the Erythropoietin Receptor Are Sufficient for Jak2 Binding/Activation and Function Mol. Cell. Biol., November 15, 2006; 26(22): 8527 - 8538. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |